Prevalence and risk factors of cerebral microbleeds

Background: Cerebral microbleeds are focal deposits of hemosiderin that can be visualized with MRI. Little is known on their prevalence in the general population and on their etiology. It has been suggested that, in analogy to spontaneous intracranial hemorrhage, the etiology of microbleeds differs according to their location in the brain, with lobar microbleeds being caused by cerebral amyloid angiopathy and deep or infratentorial microbleeds resulting from hypertension and atherosclerosis. We investigated the prevalence of and risk factors for microbleeds in the general population aged 60 years and older. Methods: This study is based on 1,062 persons (mean age 69.6 years) from the population-based Rotterdam Scan Study. MRI was performed at 1.5 T and included a sequence optimized to increase the conspicuity of microbleeds. We assessed the relation of APOE genotype, cardiovascular risk factors, and markers of small vessel disease to the presence and location of microbleeds with multiple logistic regression. Results: Overall prevalence of cerebral microbleeds was high and increased with age from 17.8% in persons aged 60-69 years to 38.3% in those over 80 years. APOE ε4 carriers had significantly more often strictly lobar microbleeds than noncarriers. In contrast, cardiovascular risk factors and presence of lacunar infarcts and white matter lesions were associated with microbleeds in a deep or infratentorial location but not in a lobar location. Conclusion: The prevalence of cerebral microbleeds is high. Our data support the hypothesis that strictly lobar microbleeds are related to cerebral amyloid angiopathy, whereas microbleeds in a deep or infratentorial location result from hypertensive or atherosclerotic microangiopathy.

[1]  J C Froment,et al.  Old Microbleeds Are a Potential Risk Factor for Cerebral Bleeding After Ischemic Stroke: A Gradient-Echo T2*-Weighted Brain MRI Study , 2002, Stroke.

[2]  J. Whitworth,et al.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension , 2003, Journal of hypertension.

[3]  Y. H. Kim,et al.  Cerebral microbleeds are regionally associated with intracerebral hemorrhage , 2004, Neurology.

[4]  Aad van der Lugt,et al.  Total Cerebral Blood Flow and Total Brain Perfusion in the General Population: The Rotterdam Scan Study , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  M. Ferrari,et al.  Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. , 2005, Brain : a journal of neurology.

[6]  B. Hyman,et al.  Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. , 1998, Neurology.

[7]  F. Fazekas,et al.  MR of cerebral abnormalities concomitant with primary intracerebral hematomas. , 1996, AJNR. American journal of neuroradiology.

[8]  S. Greenberg,et al.  Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.

[9]  S. I. Lee,et al.  APOE ε2/ε4 polymorphism and cerebral microbleeds on gradient-echo MRI , 2005, Neurology.

[10]  S. Greenberg,et al.  Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy , 1998, Neurology.

[11]  H. Koennecke.  Cerebral microbleeds on MRI , 2006, Neurology.

[12]  D. Werring,et al.  Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. , 2004, Brain : a journal of neurology.

[13]  J M Wardlaw,et al.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: the Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[14]  P Kapeller,et al.  MRI evidence of past cerebral microbleeds in a healthy elderly population , 1999, Neurology.

[15]  Y. Tsushima,et al.  MR Detection of microhemorrhages in neurologically healthy adults , 2002, Neuroradiology.

[16]  D. Graham,et al.  High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy , 1997, Annals of neurology.

[17]  A Hofman,et al.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[18]  J. Szaflarski,et al.  Genetic and Environmental Risk Factors for Intracerebral Hemorrhage: Preliminary Results of a Population-Based Study , 2002, Stroke.

[19]  Jérôme Honnorat,et al.  Thrombolysis for Ischemic Stroke in Patients with Old Microbleeds on Pretreatment MRI , 2003, Cerebrovascular Diseases.

[20]  B. Hyman,et al.  Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy , 1995 .

[21]  J. Roh,et al.  Low Concentration of Serum Total Cholesterol Is Associated With Multifocal Signal Loss Lesions on Gradient-Echo Magnetic Resonance Imaging: Analysis of Risk Factors for Multifocal Signal Loss Lesions , 2002, Stroke.

[22]  R Stewart,et al.  Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study , 2001, Neurology.

[23]  D. Werring,et al.  Cerebral microbleeds are common in ischemic stroke but rare in TIA , 2005, Neurology.

[24]  Jia Liu,et al.  Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages , 2003, Neurology.

[25]  B. Yoon,et al.  APOE epsilon2/epsilon4 polymorphism and cerebral microbleeds on gradient-echo MRI. , 2005, Neurology.

[26]  J. Jeret.  Prevalence and severity of microbleeds in a memory clinic setting , 2007, Neurology.

[27]  H P Hartung,et al.  Frequency and Location of Microbleeds in Patients With Primary Intracerebral Hemorrhage , 2000, Stroke.

[28]  B. Hyman,et al.  Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. , 1995, Annals of neurology.

[29]  R N Kalaria,et al.  Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. , 1996, The American journal of pathology.

[30]  K. Furie,et al.  Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. , 2000, The New England journal of medicine.

[31]  Rhoda Au,et al.  Cerebral Microbleeds: Prevalence and Associations With Cardiovascular Risk Factors in the Framingham Study , 2004, Stroke.

[32]  J. Farmer.  High-dose atorvastatin after stroke or transient ischemic attack. , 2007, Current atherosclerosis reports.

[33]  T. Imaizumi,et al.  Dotlike hemosiderin spots on T2*-weighted magnetic resonance imaging as a predictor of stroke recurrence: a prospective study. , 2004, Journal of neurosurgery.

[34]  J. Nicoll,et al.  Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage , 2004, The Lancet Neurology.

[35]  P Kapeller,et al.  Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. , 1999, AJNR. American journal of neuroradiology.

[36]  Wiro J. Niessen,et al.  Brain tissue volumes in the general elderly population The Rotterdam Scan Study , 2008, Neurobiology of Aging.

[37]  D. Reed.  The paradox of high risk of stroke in populations with low risk of coronary heart disease. , 1990, American journal of epidemiology.

[38]  T. Imaizumi,et al.  Dotlike Hemosiderin Spots Are Associated With Past Hemorrhagic Strokes in Patients With Lacunar Infarcts , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[39]  PhilipR. Wenham,et al.  Apolipoprotein E genotyping by one-stage PCR , 1991, The Lancet.

[40]  H. Chabriat,et al.  Cerebral microhemorrhage. , 2006, Stroke.

[41]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[42]  G. Persijn,et al.  Results of acute heart retransplantation , 1991, The Lancet.